2016 American Transplant Congress » Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

5:30pm-7:30pm

3D-FLM (First, Last, Max): A Novel Summative Measure of Hepatocellular Carcinoma (HCC) Tumor Burden Predicts HCC Recurrence After Liver Transplantation (LT).

E. Nordstrom,¹ J. Dodge,² J. Gralla,¹ K. Campbell,¹ C. Palmer,¹ S. Biggins.¹

5:30pm-7:30pm

A Comparative Intention-to-Treat Analysis of Liver Transplantation for HCC – Living Donor Liver Transplant vs. Deceased Donor Liver Transplant.

K. Tomiyama, N. Goldaracena, A. Barbas, M. Dib, G. Levy, L. Lilly, A. Ghanekar, I. McGilvray, E. Renner, M. Bhat, M. Selzner, M. Cattral, N. Selzner, P. Greig, D. Grant, G. Sapisochin.

5:30pm-7:30pm

Assessing the Role of Everolimus in Reducing Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation for Patients within UCSF Criteria: Re-Inventing the Role of Mammalian Target of Rapamycine Inhibitors.

L.-B. Jeng, A. Thorat, H.-R. Yang, T.-H. Chen, S.-C. Hsu.

5:30pm-7:30pm

Clinical Analysis of Patients with Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.

D. Kim, G. Na, T. Hong, Y. You.

5:30pm-7:30pm

Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.

O. Serrano,¹ A. Bangdiwala,² D. Vock,² V. Kirchner,¹ K. Yadav,¹ A. Pugalendhi,¹ E. Minja,¹ T. Dunn,¹ E. Finger,¹ A. Matas,¹ R. Kandaswamy,¹ W. Payne,¹ T. Pruett,¹ S. Chinnakotla.¹

5:30pm-7:30pm

Comparative Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma (HCC-CCA) Undergoing Liver Transplantation: A Single Center Matched Cohort Analysis.

K. Lunsford, M. Harlander-Locke, J. Gornbein, A. Zarrinpar, F. Kaldas, H. Yersiz, D. Farmer, R. Busuttil, V. Agopian.

5:30pm-7:30pm

Dysfunctional Production of Adipocytokines in Obesity Results in Inferior Oncologic Outcomes from Hepatocellular Carcinoma Following Liver Transplantation.

A. Mathur, E. Presbyskowski, D. Carpenter, E. Zorn, J. Guarrera, B. Samstein, A. Griesemer, K. Halazun, Y. Veras, K. Tomoaki, J. Emond.

5:30pm-7:30pm

Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.

T. Sandow,¹ D. DeVun,¹ P. Gulotta,¹ H. Bohorquez,² D. Kirsch.¹

5:30pm-7:30pm

Intraoperative Blood Loss Is a Promoter of Early Tumor Recurrence in Liver Transplant Patients with High Risk Hepatocellular Carcinoma.

A. Kornberg,¹ U. Witt,¹ J. Kornberg,² H. Friess,¹ K. Müller,³ K. Thrum.⁴

5:30pm-7:30pm

Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation.

C. Desai,¹ R. Varghese,² S. Robertazzi,¹ C. Di Poto,² A. Ferrarini,² C. Tu,² R. Girlanda,¹ K. Khan,¹ T. Fishbein,¹ H. Ressom.²

5:30pm-7:30pm

Occult Multifocal Hepatocellular Carcinoma in Surgical Patients.

D. Aufhauser Jr,¹ E. Sadot,² D. Murken,¹ K. Eddinger,¹ D. Goldberg,³ E. Furth,⁴ P. Abt,¹ R. DeMatteo,² M. Levine.¹

5:30pm-7:30pm

Pre-Transplant Intra-Arterial Liver Directed Therapy Does Not Increase the Risk of Hepatic Arterial Misadventures in Liver Transplantation.

J. Kallini,² A. Gabr,² R. Salem,² R. Lewandowski,² T. Baker.¹

5:30pm-7:30pm

Predictive Value of Preoperation Serum Gamma-Glutamyltranspeptidase for Hepatocellular Carcinoma Prognosis After Liver Transplantation.

S. Fu, Q. Zhao, M. Chen, L. Wu, Q. Ren, F. Ji, Z. Guo, X. He.

5:30pm-7:30pm

Selection of Patients with Solitary Lesion of Hepatocellular Cancer for Liver Transplantation.

M. Grąt,¹ J. Stypułkowski,¹ W. Patkowski,¹ K. Wronka,¹ M. Wasilewicz,² K. Grąt,³ L. Masior,¹ M. Krasnodębski,¹ Z. Lewandowski,⁴ M. Krawczyk.¹

5:30pm-7:30pm

Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit?

A. Daoud, L. Teeter, M. Ghobrial, E. Graviss, S. Mogawer, A. Sholkamy, M. Alshazly, H. Monsour, A. Gaber.

5:30pm-7:30pm

Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

5:30pm-7:30pm

Which Is the Predictable Value of Post-Transplant HCC Recurrence Between Tumor-Related Factors at the Initial Diagnosis and the Transplantation?

J. Lee,^1,2 J. Lee,¹ J. Lee,³ S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ M. Ju,^1,2 M. Kim,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2

5:30pm-7:30pm

Which Is the Predictable Values of Post-Transplant Hepatocellular Carcinoma Recurrence in Patients Received Down Staging Therapy or Bridging Therapy?

S. Song, J. Lee, S.-K. Kwon, J. Lee, J. Lee, D. Han, G. Choi, M. Kim, J. Choi, S. Kim, D. Joo.